EIF4G1 stood out as another interesting candidate driver in AML and lymphoid entities, supported by previous analyses suggesting that EIF4G1 is involved in cell survival in AML as a downstream target of MYCN, a known oncogene in neuroblastoma [97]. Here, MYCN is linked to acute myeloid leukemia.